{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-008761","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.881260+00:00","generated_at":"2026-05-22T11:49:51.570238+00:00","sec_items":["1.01","3.02"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Hepion in-licenses diagnostic tests from New Day Diagnostics for $0.725M upfront","bullets":["In-licensed celiac, respiratory multiplex (COVID/flu A/B/RSV), H. pylori, and HCC tests; three have CE marks for EU sale.","Upfront consideration: $525k cash + $200k in unregistered common stock to New Day Diagnostics.","Milestone payments up to $17.15M on regulatory, sales, and reimbursement milestones; royalties in upper single to low double digits.","Binding LOI is effective immediately; termination requires mutual consent. Parties to execute definitive license agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-008761","json":"https://secwatch.observer/filing/0001641172-25-008761.json","markdown":"https://secwatch.observer/filing/0001641172-25-008761.md","text":"https://secwatch.observer/filing/0001641172-25-008761.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225008761/0001641172-25-008761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000164117225008761/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T11:49:51.570238+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}